1. Home
  2. TCMD vs SCTX Comparison

TCMD vs SCTX Comparison

Compare TCMD & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

N/A

Current Price

$25.63

Market Cap

541.6M

Sector

Health Care

ML Signal

N/A

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$12.10

Market Cap

297.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCMD
SCTX
Founded
1995
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.6M
297.2M
IPO Year
2016
2026

Fundamental Metrics

Financial Performance
Metric
TCMD
SCTX
Price
$25.63
$12.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$36.33
★ $57.00
AVG Volume (30 Days)
186.9K
★ 360.4K
Earning Date
11-02-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 17.14
N/A
EPS
★ 0.57
N/A
Revenue
N/A
N/A
Revenue This Year
$9.95
N/A
Revenue Next Year
$9.49
N/A
P/E Ratio
$45.61
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.53
$12.58
52 Week High
$37.77
$39.60

Technical Indicators

Market Signals
Indicator
TCMD
SCTX
Relative Strength Index (RSI) 53.31 31.53
Support Level $23.14 N/A
Resistance Level $27.06 $18.30
Average True Range (ATR) 1.33 1.61
MACD -0.10 -0.18
Stochastic Oscillator 59.65 3.50

Price Performance

Historical Comparison
TCMD
SCTX

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: